Pfizer (Spain)
In research, Pfizer (Spain) stands highest in Medicine (#9,328 of 17,978 worldwide) and Health Sciences (#11,675 of 20,462 worldwide), over all time.
- World rank, all time
- #27,298 of 42,892
- Rank in Spain
- #649 of 927
- Research works
- 299 ▼ 18% vs 2013–17
- Citations
- 5.8k 19.3 per fractional work
- Top-10% rate
- 17.2% record average 16.5%
- Open access
- 39% world 28%
What is Pfizer (Spain) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #9,328 of 17,978 | 16.0% | 202 | |
| Health SciencesDomain | #11,675 of 20,462 | 16.1% | 213 |
Each strip is that field’s whole ranked pool, with the notch where Pfizer (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.
- Immunology and Microbiology 4.9×
- Medicine 4.0×
- Health Professions 1.4×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Economics, Econometrics and Finance 1.1×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Nursing 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Mathematics 0.1×
- Neuroscience 0.1×
- Computer Science 0.1×
- Chemistry 0.0×
- Materials Science 0.0×
- Environmental Science 0.0×
Who are the top researchers at Pfizer (Spain)?
Ranked on the composite score, Javier Rejas and Javier Soto Álvarez lead among researchers whose main affiliation is Pfizer (Spain).
- 1 Javier Rejas Spain · #1,026,947 worldwide 49 citations · 49 works
- 2 Javier Soto Álvarez Spain · #1,171,736 worldwide 3 citations · 17 works
Which keywords describe research at Pfizer (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Clinical Practice Guidelines, Human Metapneumovirus, Respiratory Syncytial Virus, Diagnosis, Autoantibodies, Treatment and Antimicrobial Resistance.
- Cardiovascular Magnetic Resonance
- Thrombosis
- International Myeloma Working Group
- Diagnosis Criteria
- ACE2 Receptor
- Risk Factors
- Stroke Prevention
- Prophylaxis
- Atrial Fibrillation
- Guidelines
- Anticoagulant Therapy
- Pneumococcal Conjugate Vaccine
- Vaccination
- Pathogenesis
- Cardiovascular Risk
- Cytokines
- Autoantibodies
- Inflammation
- Respiratory Syncytial Virus
- Clinical Practice Guidelines
- Epidemiology
- Human Metapneumovirus
- Diagnosis
- Treatment
- Antimicrobial Resistance
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
- Rheumatoid Arthritis
- Community-Acquired Pneumonia
- Vaccine
- Catheter Ablation
- SARS-CoV-2
- Immune Response
- Quality of Life
- Clinical Trials
- Minimal Residual Disease
- Antithrombotic Therapy
- Immunity
- Pulmonary Embolism
- Venous Thromboembolism
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology12▲ 7.2×37 topics
- Clinical Practice Guidelines4▲ 15×5 topics
- Human Metapneumovirus3▲ 161×1 topic
- Respiratory Syncytial Virus3▲ 161×1 topic
- Diagnosis3▲ 7.6×12 topics
- Inflammation3▲ 3.1×12 topics
- Treatment3▲ 5.3×8 topics
- Autoantibodies3▲ 27×5 topics
- Antimicrobial Resistance2▲ 27×3 topics
- Cytokines2▲ 18×3 topics
- Biological Therapy2▲ 87×1 topic
- Cardiovascular Risk2▲ 16×2 topics
- Disease-Modifying Antirheumatic Drugs2▲ 98×1 topic
- Pathogenesis2▲ 9.5×10 topics
- Rheumatoid Arthritis2▲ 52×2 topics
- Vaccination2▲ 67×2 topics
- Community-Acquired Pneumonia2▲ 138×1 topic
- Pneumococcal Conjugate Vaccine2▲ 138×1 topic
- Vaccine2▲ 11×6 topics
- Anticoagulant Therapy2▲ 33×3 topics
- Catheter Ablation2▲ 34×2 topics
- Guidelines2▲ 9.0×5 topics
- SARS-CoV-22▲ 13×5 topics
- Atrial Fibrillation2▲ 39×1 topic
- Immune Response2▲ 6.8×7 topics
- Prophylaxis2▲ 31×3 topics
- Quality of Life2▲ 2.8×10 topics
- Stroke Prevention2▲ 32×1 topic
- Clinical Trials2▲ 5.3×7 topics
- Risk Factors2▲ 3.3×6 topics
- Minimal Residual Disease1▲ 49×2 topics
- ACE2 Receptor1▲ 12×2 topics
- Antithrombotic Therapy1▲ 35×2 topics
- Diagnosis Criteria1▲ 80×1 topic
- Immunity1▲ 6.9×3 topics
- International Myeloma Working Group1▲ 80×1 topic
- Pulmonary Embolism1▲ 44×1 topic
- Thrombosis1▲ 10.0×4 topics
- Venous Thromboembolism1▲ 44×1 topic
- Cardiovascular Magnetic Resonance1▲ 44×2 topics
Which research topics does Pfizer (Spain) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Rheumatoid Arthritis Research and Therapies, Pneumonia and Respiratory Infections and Atrial Fibrillation Management and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 3 works
- 2 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
- 3 Pneumonia and Respiratory Infections Epidemiology 2 works
- 4 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 2 works
- 5 Venous Thromboembolism Diagnosis and Management Internal Medicine 1 works
- 6 Multiple Myeloma Research and Treatments Hematology 1 works
- 7 Autoimmune and Inflammatory Disorders Research Hematology 1 works
- 8 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 Spondyloarthritis Studies and Treatments Rheumatology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Spain)'s research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.